Compare FBIZ & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBIZ | TLRY |
|---|---|---|
| Founded | 1909 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.7M | 570.4M |
| IPO Year | 2012 | 2018 |
| Metric | FBIZ | TLRY |
|---|---|---|
| Price | $63.80 | $4.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $66.00 | ★ $72.33 |
| AVG Volume (30 Days) | 48.1K | ★ 3.5M |
| Earning Date | 04-23-2026 | 04-01-2026 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | ★ 14.23 | N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.69 | $8.79 |
| Revenue Next Year | $8.47 | $19.98 |
| P/E Ratio | $44.24 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $45.90 | $0.55 |
| 52 Week High | $65.49 | $15.70 |
| Indicator | FBIZ | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 59.23 | 38.44 |
| Support Level | $53.68 | $0.77 |
| Resistance Level | $65.49 | $4.85 |
| Average True Range (ATR) | 1.44 | 0.23 |
| MACD | -0.14 | 0.02 |
| Stochastic Oscillator | 55.50 | 37.69 |
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.